Brown Brothers Harriman & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
|
|||||
|
2025
Q1 | $1.37M | Sell |
|
|||||
|
2024
Q4 | $1.14M | Buy |
|
|||||
|
2024
Q3 | $1.15M | Sell |
|
|||||
|
2024
Q2 | $1.17M | Buy |
|
|||||
|
2024
Q1 | $1M | Sell |
|
|||||
|
2023
Q4 | $1.02M | Sell |
|
|||||
|
2023
Q3 | $940K | Buy |
|
|||||
|
2023
Q2 | $922K | Buy |
|
|||||
|
2023
Q1 | $796K | Buy |
|
|||||
|
2022
Q4 | $713K | Sell |
|
|||||
|
2022
Q3 | $718K | Buy |
|
|||||
|
2022
Q2 | $694K | Buy |
|
|||||
|
2022
Q1 | $631K | Buy |
|
|||||
|
2021
Q4 | $513 | Sell |
|
|||||
|
2021
Q3 | $483 | Sell |
|
|||||
|
2021
Q2 | $547 | Sell |
|
|||||
|
2021
Q1 | $618 | Sell |
|
|||||
|
2020
Q4 | $818K | Buy |
|
|||||
|
2020
Q3 | $94K | Hold |
|
|||||
|
2020
Q2 | $100K | Sell |
|
|||||
|
2020
Q1 | $115K | Sell |
|
|||||
|
2019
Q4 | $296K | Buy |
|
|||||
|
2019
Q3 | $94K | Buy |
|
|||||
|
2019
Q2 | $92K | Buy |
|
|||||
|
2019
Q1 | $76K | Sell |
|
|||||
|
2018
Q4 | $87K | Buy |
|
|||||
|
2018
Q3 | $72K | Buy |
|
|||||
|
2018
Q2 | $63K | Buy |
|
|||||
|
2018
Q1 | $25K | Sell |
|
|||||
|
2017
Q4 | $28K | Buy |
|
|||||
|
2017
Q3 | $27K | Hold |
|
|||||
|
2017
Q2 | $23K | Buy |
|
|||||
|
2017
Q1 | $2K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $9K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $3K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $3K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $134K | Buy |
|